Abstract
We demonstrate that universal scaling behavior is observed in the current coronavirus (SARS-CoV-2) spread, the COVID-19 pandemic, in various countries. We analyze the numbers of infected people who tested positive (cases) in selected eleven countries (Japan, USA, Russia, Brazil, China, Italy, Indonesia, Spain, South Korea, UK, and Sweden). By using the double exponential function called the Gompertz function, fG(x) = exp(−e−x), the number of cases is well described as N(t) = N0fG(γ(t − t0)), where N0, 7 and t0 are the final number of cases, the damping rate of the infection probability and the peak time of the daily number of new cases, dN(t)/dt, respectively. The scaled data of cases in most of the analyzed countries are found to collapse onto a common scaling function fG(x) with x = γ(t − t0) being the scaling variable in the range of fG(x) ± 0.05. The recently proposed indicator so-called the K value, the increasing rate of cases in one week, is also found to show universal behavior. The mechanism for the Gompertz function to appear is discussed from the time dependence of the produced pion numbers in nucleus-nucleus collisions, which is also found to be described by the Gompertz function.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported in part by the Grants-in-Aid for Scientific Research from JSPS (Nos. 19H01898 and 19H05151).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We use data opened to public and available on the web.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
† Report number: YITP-20-82
References are updated. Simplified model analysis on the pion production is added. The analysis of number of cases in July and August is also added in the Appendix B.
Data Availability
We use data opened to public and available on the web. https://ourworldindata.org/coronavirus-source-data https://covidtracking.com/
